|
It was reported that on (b)(6) 2026, a 29mm tendyne mitral valve was chosen for implant.Post-procedure, patient had experienced heart failure symptoms and required medication, milrinone, before weaning off and recovering and in physiotherapy.On an unknown date, patient experienced unknown electrocardiogram (ecg) rhythm issues but it was unclear if previously placed epicardial pacer leads were used or effective in pacing the heart.It was then reported on (b)(6) 2026 the patient experienced cardiac arrest and was placed on extra corporeal membranous oxygen (ecmo) therapy on (b)(6) 2026.Post cardiac arrest, patient had severely depressed ejection fraction.A decision was made to place an impella device to vent the left ventricle on (b)(6) 2026.On (b)(6) 2026, an echocardiogram noted the tendyne valve was significantly thrombosed while still on ecmo and with impella.A decision was made to withdraw care and patient passed away on (b)(6) 2026.
|